Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.43 | -0.16 | 176.57 |
| EPS, GAAP | -0.43 | -0.16 | -0.16 |
| Consensus Estimate | -0.50 | -0.16 | 207.69 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -0.56 | -0.56 | 1.07 |
| EPS, GAAP | -0.56 | -0.56 | 1.07 |
| Consensus Estimate | -0.61 | -0.57 | 7.96 |
| MDVN | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.20 |
| Price/Sales | 20.44 | 18.91 |
| Beta | 1.22 | 0.70 |
| 1/9/2013 | The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS) (24/7 Wall St) |
| 12/5/2012 | FDA Drug Approvals Increase (WSJ.com) |
